financetom
Business
financetom
/
Business
/
Arch Resources Insider Sold Shares Worth $15,845,430, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arch Resources Insider Sold Shares Worth $15,845,430, According to a Recent SEC Filing
Mar 8, 2024 11:07 AM

01:33 PM EST, 03/08/2024 (MT Newswires) -- John W Eaves, Director, Executive Chairman, on March 07, 2024, sold 85,555 shares in Arch Resources ( ARCH ) for $15,845,430. Following the Form 4 filing with the SEC, Eaves has control over a total of 124,116 shares of the company, with 124,116 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1037676/000095017024028501/xslF345X03/ownership.xml

Price: 184.60, Change: +0.01, Percent Change: +0.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
'Is This Just Fantasy?' Sony Buys Queen Music Catalog For Over $1 Billion
'Is This Just Fantasy?' Sony Buys Queen Music Catalog For Over $1 Billion
Jun 20, 2024
Sony Group Corp ( SONY ). is poised to acquire Queen’s music catalog in a groundbreaking deal worth £1 billion (US$1.27 billion). According to Hits‘ Rumor Mill, Sony Music Entertainment will secure Queen's recording and publishing rights. The deal, later confirmed by Variety, includes royalties from previous agreements with Disney Music Group and Universal Music Group NV ( UMGNF )...
Kyverna Therapeutics Gets FDA Investigational New Drug Application Clearance for KYV-101 to Treat Stiff-Person Syndrome
Kyverna Therapeutics Gets FDA Investigational New Drug Application Clearance for KYV-101 to Treat Stiff-Person Syndrome
Jun 20, 2024
10:18 AM EDT, 06/20/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said Thursday the US Food and Drug Administration has cleared the company's Investigational New Drug application for KYV-101, a candidate for therapy to treat stiff-person syndrome to be used a Kyverna trial. SPS is a rare, progressive autoimmune disorder that causes severe muscle stiffness in the torso, arms,...
Accuray, TrueNorth Medical Physics Collaborate on Radiation Oncology Support
Accuray, TrueNorth Medical Physics Collaborate on Radiation Oncology Support
Jun 20, 2024
10:28 AM EDT, 06/20/2024 (MT Newswires) -- Accuray ( ARAY ) said Thursday that it has entered into a deal with TrueNorth Medical Physics to provide support to radiation oncology departments. Per the deal, TrueNorth Medical Physics will provide services that complement and supplement those offered by Accura, acting as an extension of the hospital team, and providing on-site, remote,...
Anthropic launches newest AI model, three months after its last
Anthropic launches newest AI model, three months after its last
Jun 20, 2024
June 20 (Reuters) - Anthropic, a startup backed by Google and Amazon.com ( AMZN ), on Thursday released an updated artificial intelligence model and a new layout to boost user productivity, continuing an industry sprint to push technology's frontier. Three months after rolling out its Claude 3 family of AI models, Anthropic said it was launching Claude 3.5 Sonnet. Compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved